Company Filing History:
Years Active: 2012
Title: Sabrina Liberatori: Innovator in Vaccine Development
Introduction
Sabrina Liberatori is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of vaccine development, particularly focusing on protective antigens for Group B hypervirulent strains. Her work is crucial in the ongoing efforts to combat these strains through innovative vaccine compositions.
Latest Patents
Sabrina holds 1 patent for her invention, which provides protective antigens specifically designed for Group B hypervirulent strains. The fragments she developed are instrumental in creating vaccine compositions that induce protection against these particularly virulent strains.
Career Highlights
Sabrina is currently employed at Novartis AG, where she continues to advance her research and development efforts in the pharmaceutical industry. Her expertise and innovative approach have positioned her as a valuable asset in her field.
Collaborations
Throughout her career, Sabrina has collaborated with notable colleagues, including Francesco Doro and Nathalie Norais. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Sabrina Liberatori's work in vaccine development exemplifies the impact of innovation in addressing public health challenges. Her contributions are paving the way for more effective solutions against hypervirulent strains.